Midas Medici to price public stock sale at $3.00 to $4.00 per share

Proceeds fund debt repayment, marketing initiatives, working capital

By Devika Patel

Knoxville, Tenn., Feb. 7 - Midas Medici Group Holdings, Inc. plans to price a public sale of stock, according to an S-1 filing made with the Securities and Exchange Commission on Tuesday. The deal will have a 45-day 15% greenshoe.

The company will sell 6 million common shares at a price that is expected to be between $3.00 and $4.00 per share.

Proceeds will be used to repay debt, increase long-term contracts, for acquisition and transaction costs, marketing initiatives, working capital and general corporate purposes.

The registration also covers 2,297,022 shares to be offered by selling stockholders in a secondary sale.

Midas is a New York-based provider of information technology solutions to commercial enterprises and government institutions in the United States and Brazil.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.